Drug intelligence / Profile preview

DWC20141 + DWC20142

Development stage: Unknown
Lead developer: Daewoong Pharmaceutical

Overview

DWC20141 + DWC20142 is a combination of two investigational compounds developed by Daewoong Pharmaceutical for pharmacokinetic and drug interaction studies. It has been tested in healthy male volunteers to assess drug-drug interaction and pharmacokinetic characteristics[1][3]. The specific mechanisms of action, molecular structures, targeted indications, and modalities for DWC20141 and DWC20142 have not been publicly disclosed.

Beyond the preview

Go deeper on DWC20141 + DWC20142.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DWC20141 + DWC20142.

Explore the full profile